Pharma Sector Insights from Carter Worth

Carter Worth of Worth Charting discussed bullish reversal patterns in the pharmaceutical sector. He highlighted potential upside in Merck, Biogen, and Pfizer, suggesting that underperforming stocks might present greater opportunities compared to Johnson & Johnson.